Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update (English)
- New search for: Johnson, JA
- New search for: Caudle, KE
- New search for: Gong, L
- New search for: Whirl‐Carrillo, M
- New search for: Stein, CM
- New search for: Scott, SA
- New search for: Lee, MT
- New search for: Gage, BF
- New search for: Kimmel, SE
- New search for: Perera, MA
- New search for: Anderson, JL
- New search for: Pirmohamed, M
- New search for: Klein, TE
- New search for: Limdi, NA
- New search for: Cavallari, LH
- New search for: Wadelius, M
- New search for: Johnson, JA
- New search for: Caudle, KE
- New search for: Gong, L
- New search for: Whirl‐Carrillo, M
- New search for: Stein, CM
- New search for: Scott, SA
- New search for: Lee, MT
- New search for: Gage, BF
- New search for: Kimmel, SE
- New search for: Perera, MA
- New search for: Anderson, JL
- New search for: Pirmohamed, M
- New search for: Klein, TE
- New search for: Limdi, NA
- New search for: Cavallari, LH
- New search for: Wadelius, M
In:
Clinical Pharmacology & Therapeutics
;
102
, 3
;
397-404
;
2017
- Article (Journal) / Electronic Resource
-
Title:Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update
-
Contributors:Johnson, JA ( author ) / Caudle, KE ( author ) / Gong, L ( author ) / Whirl‐Carrillo, M ( author ) / Stein, CM ( author ) / Scott, SA ( author ) / Lee, MT ( author ) / Gage, BF ( author ) / Kimmel, SE ( author ) / Perera, MA ( author )
-
Published in:Clinical Pharmacology & Therapeutics ; 102, 3 ; 397-404
-
Publisher:
-
Publication date:2017-09-01
-
Size:8 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Source:
Table of contents – Volume 102, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 359
-
Issue Information| 2017
- 367
-
In This Issue| 2017
- 368
-
Drugs and the Kidneys: Clinical Pharmacology PerspectivesVincent, John et al. | 2017
- 373
-
Peer Review Certifies Quality and Innovation in Clinical Pharmacology & TherapeuticsWaldman, SA / Terzic, A et al. | 2017
- 378
-
Highlights| 2017
- 380
-
ASCPT NEWS| 2017
- 387
-
Evaluating the Renal Safety of Investigational New Drugs: Where Should We Be Going?Stockbridge, N / Blank, M / Hausner, EA / Thompson, A et al. | 2017
- 389
-
Impact of Hyperkalemia and Worsening Renal Function on the Use of Renin Angiotensin Aldosterone System Inhibitors in Chronic Heart Failure With Reduced Ejection FractionPitt, B / Rossignol, P et al. | 2017
- 391
-
A Call for a Consortium for Optimal Management of Drug–Drug Interactions in Patient CareBurger, DM / Smolders, EJ / Schapiro, J / Drenth, JPH / Back, DJ et al. | 2017
- 395
-
PPARδ Modulation by GW501516: An Unsuccessful Exercise MimeticSanchis‐Gomar, F / Lippi, G / Perez‐Quilis, C et al. | 2017
- 396
-
Response to “PPARδ Modulation by GW501516: An Unsuccessful Exercise Mimetic”Li, S / Laher, I et al. | 2017
- 397
-
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 UpdateJohnson, JA / Caudle, KE / Gong, L / Whirl‐Carrillo, M / Stein, CM / Scott, SA / Lee, MT / Gage, BF / Kimmel, SE / Perera, MA et al. | 2017
- 405
-
Assessment of Glomerular Filtration Rate in Health and Disease: A State of the Art ReviewLevey, AS / Inker, LA et al. | 2017
- 420
-
Emerging Targets of Diuretic TherapyCheng, C‐J / Rodan, AR / Huang, C‐L et al. | 2017
- 436
-
The Role of the Kidney in Drug Elimination: Transport, Metabolism, and the Impact of Kidney Disease on Drug ClearanceMiners, JO / Yang, X / Knights, KM / Zhang, L et al. | 2017
- 450
-
Renal Targeted Therapies of Antihypertensive and Cardiovascular Drugs for Patients With Stages 3 Through 5d Kidney DiseaseAI Dhaybi, O / Bakris, GL et al. | 2017
- 459
-
The Nephrotoxicity of VancomycinFilippone, EJ / Kraft, WK / Farber, JL et al. | 2017
- 470
-
Renal Effects of SGLT‐2 Inhibitors and Other Anti‐diabetic Drugs: Clinical Relevance and Potential RisksLioudaki, E / Whyte, M / Androulakis, ES / Stylianou, KG / Daphnis, EK / Ganotakis, ES et al. | 2017
- 481
-
Biomarkers of Renal Function: Towards Clinical ActionabilityBinnenmars, S Heleen / Hijmans, RS / Navis, G / de Borst, MH et al. | 2017
- 493
-
Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype‐Guided Antiplatelet TherapyHarada, S / Zhou, Y / Duncan, S / Armstead, AR / Coshatt, GM / Dillon, C / Brott, BC / Willig, J / Alsip, JA / Hillegass, WB et al. | 2017
- 502
-
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare SystemsLuzum, JA / Pakyz, RE / Elsey, AR / Haidar, CE / Peterson, JF / Whirl‐Carrillo, M / Handelman, SK / Palmer, K / Pulley, JM / Beller, M et al. | 2017
- 511
-
Associations of High‐Dose Melphalan Pharmacokinetics and Outcomes in the Setting of a Randomized Cryotherapy TrialCho, YK / Sborov, DW / Lamprecht, M / Li, J / Wang, J / Hade, EM / Gao, Y / Tackett, K / Williams, N / Benson, DM et al. | 2017
- 520
-
Antiretroviral Therapy With Efavirenz Accentuates Pregnancy‐Associated Reduction of Dihydroartemisinin‐Piperaquine Exposure During Malaria ChemopreventionKajubi, R / Huang, L / Jagannathan, P / Chamankhah, N / Were, M / Ruel, T / Koss, CA / Kakuru, A / Mwebaza, N / Kamya, M et al. | 2017
- 529
-
The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or NevirapineNeary, M / Lamorde, M / Olagunju, A / Darin, KM / Merry, C / Byakika‐Kibwika, P / Back, DJ / Siccardi, M / Owen, A / Scarsi, KK et al. | 2017
- 537
-
An Accelerator Mass Spectrometry‐Enabled Microtracer Study to Evaluate the First‐Pass Effect on the Absorption of YH4808Kim, A / Yu, B‐Y / Dueker, SR / Shin, K‐H / Kim, HS / Ahn, H / Cho, J‐Y / Yu, K‐S / Jang, I‐J / Lee, H et al. | 2017
- 547
-
Clopidogrel–Paclitaxel Drug–Drug Interaction: A Pharmacoepidemiologic StudyAgergaard, K / Mau‐Sørensen, M / Stage, TB / Jørgensen, TL / Hassel, RE / Steffensen, KD / Pedersen, JW / Milo, MLH / Poulsen, SH / Pottegård, A et al. | 2017